Valdés SO, Rodriguez CY, Delgado SE, Fernández CE

Language: Spanish
References: 16
Page: 86-96
PDF size: 451.17 Kb.

ABSTRACT

The bronchial asthma is present in a 4.7% of pregnant women. The course during the pregnancy is variable, a third remains stable, another third improves and the rest worsens. On the other hand, the acute respiratory distress syndrome (ARDS) is associated with a high mobility and mortality. When both conditions are present in the same patient it is more complex because the mechanical ventilation strategies that are beneficial for a condition could be deleterious for the other. We showed the description of a pregnant patient with 15.3 gestation weeks that presented initially an acute respiratory failure of hypercapnic predominion for status asthmaticus that was not solved with the conventional measures, it was used inhalated anesthesia gases and that progressively she presented worsening of the respiratory failure associated with an acute respiratory distress syndrome of lung direct cause and it was used, like another not conventional measure, endotracheal external lung surfactant (Surfacen).

REFERENCES

1. Zubiría CE, Zubiría SE, Zubiría SA. Conceptos básicos de asma bronquial. Bogotá; Quebecor Impreandes, 1999.

2. Montejo JC, García de Lorenzo A, Ortiz Leyba C, Planas M. Manual de medicina intensiva. Madrid: Mosby/Doyma Libros, 1996.

3. Fanta CH. Clinical aspects of asthma. 11 th National ACCP Pulmonary Board Review Syllabus. American College of Chest Physicians, 1996.

4. Phua J, Badia JR, Adhikari NK, Friedrich JO, Fowler RA, Singh JM, et al: Has mortality from acute respiratory distress syndrome decreased overtime? A systematic review Am J Respiratory Critical Care Med. 2009;179:220–7.

5. Angel L, Arroliga A, Anzueto A. Síndrome de Distrés Respiratorio del Adulto. En: Lovesio C, editor. Medicina Intensiva. Buenos Aires: Editorial El Ateneo; 2006.

6. Bourk L P, Becker A. Studios of the Canadian Asthmacaucassy groups. Clin Report 1999 (161) pág 11.

7. Barnes PJ. Inhaled glucocorticoids for asthma. N Engl J Med 1995; 332: 868-875.

8. Robert O. Managing yours asthma during pregnancy .Disponible in http/www intermedicine.com/topic/pregnancy and asthma. 29 de abril 2001.

9. Yamkowicttz J.Are asthma treatments safe during pregnancy.Disponible in http/20ww/infomed/cu/asthma doc. 28 de abril 2001.

10. Malttais f, et al. Respiratory mechanism in status asthmaticus. Effects of inhalation anaesthesia. Chest 1994; 106 (5): pp1401-6.

11. Thornton JA. Trastornos neurológicos y musculares. En: Cecil Gray T, Nunn JF,Utting JE. Anestesia General. La Habana: Científico-Técnica, 2012; t2:823-5.

12. Allen GC. Malignant hyperthermia and associated disorders. Curr Opin Reumatol 2007; 5(6):719-24.

13. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342(18):1301-8.

14. Markart P, Ruppert C, Wygrecka M, Colaris T, Dahal B, Walmrath D, et al. Patients with ARDS show improvement but not normalisation of alveolar surface activity with surfactant treatment: putative role of neutral lipids. Thorax. 2007;62(7):588-94.

15. Díaz HM, Sosa A, Hidalgo O, Pastrana I, Díaz A. Low Doses of Surfactant in the Treatment of Adult Respiratory Distress Syndrome. 1er Congreso de Medicina Crítica en Internet. 1999 (Accedida en 21/10/2010):17-24. Disponible en: http://www.uninet.edu/cimc99/abstract/001130AO.html

16. Hidalgo AO, Fernández O, Díaz E, Faure R, et al. Eficacia y seguridad de dosis bajas y repetidas del surfactante pulmonar SURFACEN en el tratamiento del síndrome de dificultad respiratoria aguda en el adulto. VI Congreso Internacional de Urgencias, Emergencias y Cuidados Intensivos. La Habana 2013. CD ISBN: 978-959-306-129-2, pág 711.